The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

There’s a widespread myth that FDA approval of a new drug product means that that drug is safe for consumer use. Yet, according to a notice published Friday by the US Food and Drug Administration (FDA), from October 2005 through September 2006, companies had yet to initiate 71 percent of outstanding “post-market” safety evaluations that companies have promised to undertake for currently approved products they are already selling to consumers.
The drug companies are interested in profits and will often take shortcuts to increase their bottom line. We’ve seen this behavior with Merck, Eli Lilly, and other pharmaceutical giants. This is dangerous for the average consumer.

Comments are closed.

Of Interest